Trial · NCT02465359
Adverse events32
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 32
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Pain at infusion site | General disorders | Immune Globulin Subcutaneous (Human) | 13 | 15 | |
| other | Transient swelling at site of infusion | General disorders | Immune Globulin Subcutaneous (Human) | 12 | 15 | |
| other | Redness at site of infusion | General disorders | Immune Globulin Subcutaneous (Human) | 11 | 15 | |
| other | Induration at site of infusion | General disorders | Immune Globulin Subcutaneous (Human) | 7 | 15 | |
| other | Itching at site of infusion | General disorders | Immune Globulin Subcutaneous (Human) | 7 | 15 | |
| other | Numbness | General disorders | Immune Globulin Subcutaneous (Human) | 5 | 15 | |
| other | Bruising at site of infusion | General disorders | Immune Globulin Subcutaneous (Human) | 5 | 15 | |
| other | Increased Exhaustion | General disorders | Immune Globulin Subcutaneous (Human) | 4 | 15 | |
| other | Hedache/Migrane | Nervous system disorders | Immune Globulin Subcutaneous (Human) | 4 | 15 | |
| other | Local heat at site of infusion | Skin and subcutaneous tissue disorders | Immune Globulin Subcutaneous (Human) | 3 | 15 | |
| other | Increased weakness | Musculoskeletal and connective tissue disorders | Immune Globulin Subcutaneous (Human) | 3 | 15 | |
| other | Tingling sensation | Skin and subcutaneous tissue disorders | Immune Globulin Subcutaneous (Human) | 3 | 15 | |
| other | Burning sensation at site of infusion | Skin and subcutaneous tissue disorders | Immune Globulin Subcutaneous (Human) | 3 | 15 | |
| other | Fever | General disorders | Immune Globulin Subcutaneous (Human) | 2 | 15 | |
| other | Pain in the extremities | Musculoskeletal and connective tissue disorders | Immune Globulin Subcutaneous (Human) | 2 | 15 | |
| other | Fell/fainted | General disorders | Immune Globulin Subcutaneous (Human) | 2 | 15 | |
| other | Generalized itching | Skin and subcutaneous tissue disorders | Immune Globulin Subcutaneous (Human) | 1 | 15 | |
| other | Bloating | Gastrointestinal disorders | Immune Globulin Subcutaneous (Human) | 1 | 15 | |
| other | Stabbing Pain | General disorders | Immune Globulin Subcutaneous (Human) | 1 | 15 | |
| other | Backache | Musculoskeletal and connective tissue disorders | Immune Globulin Subcutaneous (Human) | 1 | 15 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02465359/events